Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chris P. Beauchamp"'
Autor:
Robert S. Bell, Aileen M. Davis, David Malkin, John H. Healey, Robert J. Grimer, Shelley B. Bull, Michael J. Rock, Ernest U. Conrad, D. C. Mangham, Chris P. Beauchamp, Jay S. Wunder, Irene L. Andrulis, Robert Parkes, Nalan Gokgoz, Sasha Eskandarian
Publikováno v:
Journal of Clinical Oncology. 23:1483-1490
Purpose Mutations of the TP53 gene have been associated with resistance to chemotherapy as well as poor prognosis in many different malignancies. This is the first prospective study of the prognostic value of somatic TP53 mutations in patients with n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89c61c871d2864e28a137774f18a3a0
https://doi.org/10.1200/jco.2005.04.074
https://doi.org/10.1200/jco.2005.04.074
Autor:
Irene L. Andrulis, Robert J. Grimer, John H. Healey, Robert S. Bell, Jay S. Wunder, Shelley B. Bull, Ernest U. Conrad, Michael J. Rock, Chris P. Beauchamp, Peter Lee, Vicky Aneliunas, Aileen M. Davis
Publikováno v:
Journal of Clinical Oncology. 18:2685-2694
PURPOSE: Increased expression of the multidrug resistance gene (MDR1) has been implicated in osteosarcoma prognosis. This study represents the first prospective assessment of the prognostic value of MDR1 mRNA expression in patients with newly diagnos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b27a3b5fbcd805e4479854430d0b854
https://doi.org/10.1200/jco.2000.18.14.2685
https://doi.org/10.1200/jco.2000.18.14.2685